Cargando…

The case for SABR as the global standard for non-operable early-stage non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Mutsaers, Adam, Louie, Alexander V., Ynoe Moraes, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903782/ https://www.ncbi.nlm.nih.gov/pubmed/36777385 http://dx.doi.org/10.1016/j.lana.2022.100361

Ejemplares similares

T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer
por: Hsu, Eric J., et al.
Publicado: (2022)

Stereotactic or Conventional Radiation for Early-Stage Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Mutsaers, Adam, et al.
Publicado: (2023)

Artificial intelligence in the medical profession: ready or not, here AI comes
por: Pucchio, Aidan, et al.
Publicado: (2022)

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?
por: Passiglia, Francesco, et al.
Publicado: (2023)

Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
por: Dhaliwal, Inderdeep, et al.
Publicado: (2022)

Stereotactic body radiotherapy versus surgery for early-stage non-small cell lung cancer: an updated meta-analysis involving 29,511 patients included in comparative studies
por: Viani, Gustavo Arruda, et al.
Publicado: (2022)

Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
por: Stares, Mark, et al.
Publicado: (2023)

Sequential or concomitant chemotherapy with hypofractionated radiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized trials
por: Viani, Gustavo Arruda, et al.
Publicado: (2021)

Comprehensive dosimetric planning comparison for early‐stage, non‐small cell lung cancer with SABR: fixed‐beam IMRT versus VMAT versus TomoTherapy
por: Xhaferllari, Ilma, et al.
Publicado: (2016)

Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team
por: Shirvani, Shervin M., et al.
Publicado: (2011)

Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
por: Maia, Fernando Henrique de Albuquerque, et al.
Publicado: (2023)

Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)
por: Palma, David A., et al.
Publicado: (2017)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
por: Vlaskou Badra, Eugenia, et al.
Publicado: (2021)

Equitable endotyping is essential to achieve a global standard of precise, effective, and locally-relevant sepsis care
por: Cummings, Matthew J., et al.
Publicado: (2022)

The use of inhaled corticosteroids in early-stage COVID-19
por: Mangin, Dee, et al.
Publicado: (2021)

Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?
por: Brooks, Eric D., et al.
Publicado: (2019)

Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176
por: Auclin, Edouard, et al.
Publicado: (2021)

Pneumomediastinum as a complication of SABR for lung metastases
por: Rodríguez-Ruiz, María Esperanza, et al.
Publicado: (2015)

Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer
por: Preti, Beatrice T. B., et al.
Publicado: (2023)

The Global Fund in China: success beyond the numbers
por: Minghui, Ren, et al.
Publicado: (2015)

Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility
por: Majumder, Maimuna S, et al.
Publicado: (2020)

Quantification of hyperpolarisation efficiency in SABRE and SABRE-Relay enhanced NMR spectroscopy
por: Richardson, Peter M., et al.
Publicado: (2018)

Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group)
por: Gould, Gillian Sandra, et al.
Publicado: (2023)

Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics
por: Klupczynska, Agnieszka, et al.
Publicado: (2017)

Unanticipated Radiation Replanning for Stage III Non-small Cell Lung Cancer
por: Mushonga, Melinda, et al.
Publicado: (2023)

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease
por: Koné-Paut, Isabelle, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
por: Lokk, Kaie, et al.
Publicado: (2012)

Surgical treatment of early-stage non-small-cell lung cancer
por: Van Schil, Paul E., et al.
Publicado: (2013)

Stereotactic radiotherapy for early stage non-small cell lung cancer
por: Ricardi, Umberto, et al.
Publicado: (2015)

DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABR
por: Mouawad, Matthew, et al.
Publicado: (2019)

Standards of care in mesothelioma treatment
por: Harden, Susan V., et al.
Publicado: (2020)

SABRE Hyperpolarization with up to 200 bar Parahydrogen in Standard and Quickly Removable Solvents
por: Duchowny, Anton, et al.
Publicado: (2023)

Response to “Ribosome Rescue and Translation Termination at Non-standard Stop Codons by ICT1 in Mammalian Mitochondria”
por: Chrzanowska-Lightowlers, Zofia Maria, et al.
Publicado: (2015)

SABRE : sistema de reservaciones para agencias de viajes
por: Mata Hernández, Elizabeth
Publicado: (1999)

Optimizing current standard of care therapy for stage III non-small cell lung cancer
por: Verma, Vivek, et al.
Publicado: (2020)

SABRE: a system for the assessment of body radioactivity ; 2, main features of SABRE 3
por: Venn, J B
Publicado: (1978)

Biased image cropping and non-independent samples
por: Brookfield, John F. Y.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dag3h7jtii1pm5vkuv6ahg0qv0